Hollis Wright Home
Mass Tort Settlements
Pharmaceutical and Medical Device Mass Tort Settlements Vioxx Settlement
In November of 2007, Merck Pharmaceuticals announced a nationwide settlement for all Vioxx related injury and death cases totaling $4.85 billion. The injuries associated with the use of Vioxx primarily involved heart attacks and strokes. The attorneys at Hollis Wright represented in excess of 100 individuals that were injured or killed while using Vioxx. Hollis Wright successfully qualified these individuals for settlement funds through the settlement program.
Zyprexa SettlementPharmaceutical giant Eli Lilly has settled approximately 28,000 cases for an estimated $1.2 billion since 2006 regarding the anti-psychotic drug Zyprexa. The injured victims asserted that the drug caused diabetes and other diseases. Hollis Wright represented approximately 1,000 individuals in this litigation and was able to provide meaningful compensation to these claimants as a result of the settlement.
DePuy ASR Hip SettlementIn November of 2013, DePuy Orthopaedics, Inc. announced a nationwide settlement to compensate eligible individuals that received an ASR hip implant. The national settlement was valued at approximately $2.5 billion. The attorneys at Hollis Wright represented several individuals that received an ASR hip implant and subsequently underwent a revision surgery to remove the ASR product. Hollis Wright successfully qualified its clients that underwent a revision surgery for settlement funds through the DePuy ASR settlement program.
Stryker Femoral Stem Hip SettlementIn November of 2014, Stryker announced a settlement of the lawsuits involving patients whose Rejuvenate or ABG II hip replacement systems were revised prior to November 3, 2014. This settlement was valued at over $1 billion. The attorneys at Hollis Wright represented numerous individuals that qualified for this settlement.
Avandia SettlementIn 2012, the attorneys at Hollis Wright successfully resolved cases on behalf of numerous individuals that suffered injuries while taking the diabetes drug known as Avandia. GlaxoSmithKline (GSK) is the manufacturer of Avandia. The allegations in these cases concerned the increased risk of heart attacks and strokes for those individuals taking Avandia to control their blood sugar.
Hydroxycut SettlementIn 2013, Iovate Sciences agreed to settle personal injury and death cases arising from usage of its dietary supplement known as Hydroxycut. The allegations were that Hydroxycut was causing liver damage or liver toxicity sometimes resulting in liver transplants or a diagnosis of drug induced liver failure. The attorneys at Hollis Wright represented numerous individuals that qualified for compensation through the Hydroxycut settlement program.
Yaz & Yasmine SettlementBayer Pharmaceuticals agreed to pay approximately $1.7 billion in 2013 to resolve an estimated 8,000 lawsuits filed by women claiming they were injured as a result of using Bayer’s birth control drug known as Yaz and/or Yasmine. The injuries that were claimed to be linked to these birth control drugs were blood clots and strokes. The attorneys at Hollis Wright represented several women that sustained these injuries while taking Yaz or Yasmine and helped them receive significant compensation for the sustained injuries.
